The latest announcement is out from Fortis ( (TSE:FTS) ).
On May 7, 2025, Fortis Inc. announced its first quarter results, reporting net earnings of $499 million, up from $459 million in the same period last year. The increase was driven by rate base growth and favorable currency exchange rates, despite higher finance costs and other operational challenges. Fortis also received regulatory approval for FortisBC’s 2025-2027 rate framework, providing stability for future operations. The company continues to focus on its $26 billion five-year capital plan, aiming for significant growth in its rate base and supporting its long-term dividend growth targets. Additionally, Fortis is committed to reducing greenhouse gas emissions, with targets set for 2030, 2035, and 2050.
Spark’s Take on TSE:FTS Stock
According to Spark, TipRanks’ AI Analyst, TSE:FTS is a Outperform.
Fortis’s stock score reflects its solid financial performance and strategic initiatives, supported by consistent dividend growth and robust capital investments. The company’s stable operating performance and effective management of leverage are key strengths, while challenges include high capital expenditures affecting free cash flow and potential regulatory hurdles. Valuation concerns persist with a relatively high P/E ratio, tempered by a strong dividend yield. Overall, Fortis maintains a positive outlook with a stable growth trajectory.
To see Spark’s full report on TSE:FTS stock, click here.
More about Fortis
Fortis Inc. is a well-diversified leader in the North American regulated electric and gas utility industry. The company focuses on delivering affordable and reliable energy, with a commitment to annual dividend growth through 2029. Fortis operates a diversified portfolio of regulated utility businesses and is actively pursuing investment opportunities, particularly in ITC and Tucson Electric Power.
Average Trading Volume: 1,915,796
Technical Sentiment Signal: Buy
Current Market Cap: C$33.87B
Find detailed analytics on FTS stock on TipRanks’ Stock Analysis page.